Purchase Order 75N95023P00487
Award Date
8/7/23
Potential Completion Date
8/21/23
Potential Value
$20K
Funding Federal Agency
National Center for Advancing Translational Sciences
Contracting Federal Agency
National Institute on Drug Abuse
Ultimate Awardee
Not listed
PSC Category
6505 - Drugs And Biologicals
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Coralville, IA 52241, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This purchase order contract was awarded by the National Institutes of Health's National Center for Advancing Translational Sciences to Integrated DNA Technologies, Inc. for $28,510.03. Under the terms of the contract, IDT will provide custom synthesis, purification, normalization, and delivery of nine antisense oligonucleotides to the National Institute on Drug Abuse by August 15, 2023. The ASOs will support neurotoxicity studies evaluating a potential platform for predicting adverse effects of...
The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a Firm Fixed Price purchase order to Integrated DNA Technologies, Inc. (IDT) for the custom synthesis of 9 antisense oligonucleotides (ASOs) in support of a liver toxicity study. The order has a potential value of $24,912.77 and a completion date of August 24, 2023. IDT is a manufacturer of nucleic acid products that has previously provided a range of goods and...
This is a $23,851.14 firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. Department of Health and Human Services, to Integrated DNA Technologies, Inc. (IDT) for the custom synthesis of 56 antisense oligonucleotides (ASOs) for an in-vivo liver toxicology study. The award has an ultimate completion date of September 30, 2024. IDT is a leading provider of specialized nucleic acid products and services to...
The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences (NCATS) awarded a firm fixed price purchase order to Integrated DNA Technologies, Inc. (IDT) for the custom synthesis of 1,536 antisense oligonucleotides targeting the CHCHD10 gene. The $102,915.50 contract has an August 29, 2022 completion date and does not have a set-aside designation. IDT is a manufacturer of nucleic acid products that has previously supported...
This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) National Center for Advancing Translational Sciences to Integrated DNA Technologies, Inc. (IDT), a manufacturer of nucleic acid products, for the custom synthesis of 1,536 antisense oligonucleotides in support of the SARS-CoV2 project. The potential value of this contract is $102,912.00. IDT has previously received awards from federal agencies such as the NIH, Centers for Disease Control and...
This is a $14,996.96 firm-fixed-price contract awarded to Integrated DNA Technologies, Inc. (IDT) by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID). The contract is for the provision of custom oligonucleotide and RNA synthesis services. This is a call against a $100 million Blanket Purchase Agreement (BPA) between IDT and the NIH Office of Logistics and Acquisition Operations, which covers the delivery of various biological,...
This firm fixed price purchase order was awarded by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences to Integrated DNA Technologies, Inc. for $701,584. The contract calls for the synthesis of 13,492 antisense oligonucleotides in support of an ongoing SARS-CoV-2 study for the NIH National Institute on Drug Abuse. As the incumbent contractor, Integrated DNA Technologies previously synthesized the oligonucleotides...
This federal contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Integrated DNA Technologies, Inc. (IDT), a leading provider of specialized nucleic acid products and services. The $20,000 firm-fixed-price contract is for the provision of custom oligonucleotide and RNA synthesis services to support NIAID's research and public health initiatives. This is a Blanket Purchase Agreement (BPA) call order under...
This federal contract award to Integrated DNA Technologies, Inc. (IDT), a leading provider of specialized nucleic acid products and services, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health (NIH). The $58,670.92 firm-fixed-price contract is for the delivery of oligonucleotides, which are short DNA or RNA sequences used in a variety of biomedical research and clinical applications. IDT has a broader $100,000,000...
This federal contract award was issued by the National Institutes of Health (NIH) Clinical Center to Integrated DNA Technologies, Inc. (IDT), a leading provider of specialized nucleic acid products and services to the U.S. federal government. The $95,173.74 firm-fixed-price purchase order does not have a set-aside designation. IDT has provided a diverse array of products and services through its federal contract awards, including custom DNA oligonucleotides, antisense oligonucleotides for...